Rheumatology

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in rheumatoid arthritis patients.

Transitional and CD21⁻ PD-1⁺ B cells identified at diagnosis were linked to better treatment outcomes in early rheumatoid arthritis, according to a spin-off analysis of the NORD-STAR trial.

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

New findings show that eosinophilic granulomatosis with polyangiitis (EGPA) patients in remission may safely reduce mepolizumab dosage, potentially easing long-term treatment burden.

A new study highlights anti-M3R antibodies as markers of a more aggressive clinical phenotype in systemic sclerosis, particularly affecting gastrointestinal health.

Patients with rheumatoid arthritis who stopped TNF inhibitors experienced fewer flares and treatment failures on methotrexate-tacrolimus therapy compared to methotrexate alone, with no major safety concerns.

New long-term study data suggest that patients with rheumatoid arthritis who achieve sustained disease control on baricitinib 4 mg may successfully taper to 2 mg, with the majority maintaining low disease activity or recapturing control if needed.

Asthma may raise the risk of developing osteoarthritis, with socially isolated or lonely individuals facing even greater susceptibility, according to a new large-scale cohort study.